Pediatric Provider Research and Education
Brought to you by the Pediatric Antimicrobial Stewardship Program (ASP) Collaborative of the Children’s Health Network of RWJBarnabas Health.
The ASP, representing pediatric providers, including pediatric infectious disease specialists and pharmacists, exchange ideas, discuss case management strategies and develop and implement guidelines to be shared system wide, as well as be a resource for community physicians.
Read more educational information, research and best practices from the Children’s Health Network at RWJBarnabas Health in the near future.
Triple-demic: What Pediatric Providers Need to Know
Brought to you by the Pediatric Antimicrobial Stewardship Program (ASP) Collaborative of the Children’s Health Network of RWJBarnabas Health.
Influenza Update
Renuka Verma, MD
Section Chief, Pediatric Infectious Diseases,
Unterberg Children’s Hospital at Monmouth Medical Center
Influenza season is upon us and it has shown its ugly head in the pediatric population with significant impact already. Children consistently have the highest attack rates of influenza in the community during seasonal influenza epidemics. Read more
Respiratory Syncitial Virus
Uzma Hasan, MD
Divison Director Pediatric Infectious Diseases,
Cooperman Barnabas Medical Center
Respiratory syncytial virus causes acute respiratory illness in all age groups, with some being impacted more severely than others. It typically causes an upper respiratory infection but can cause lower respiratory tract infection bronchiolitis or pneumonia. Read more
Strep Update
Uzma Hasan, MD
Division Director Pediatric Infectious Diseases,
Cooperman Barnabas Medical Center
Doug DeStefano, PharmD
Corporate AVP, Pharmacy Operations
During the respiratory viral surge, an increase in invasive group A Strep disease is being reported, both in the US and in the UK. The WHO and UK Health Security Agency recently put out an advisory to alert clinicians re: rise in Gp A Strep (Strep Pyogenes infections) including fatalities. Read more
COVID-19 Vaccines for Kids
Amisha Malhotra, MD
Pediatric Infectious Diseases,
Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital,
Associate Professor of Pediatrics at Rutgers-Robert Wood Johnson Medical School
COVID-19 vaccines are recommended by the Centers for Disease Control and Prevention (CDC) for children ages 6 months and older. COVID-19 vaccination protects children against severe disease, including hospitalization. Read more
Amoxicillin Oral Suspension Shortage
Jessica Lise, PharmD, BCPPS
Pediatric Clinical Specialist, Department of Pharmacy,
Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital
Jennifer Sternbach, PharmD, BCPS, BCACP
Assistant Vice President of Clinical Pharmacy Services,
RWJBH Pharmacy
Amoxicillin oral suspension is currently unavailable in all strengths/formulations.
Due to the shortage of amoxicillin suspensions, alternative approaches
must be considered.
Read more
Lyme Disease Primer for Pediatric Providers
Peter Wenger, MD
Attending Physician, Infectious Diseases, Departments of Pediatrics
Children’s Hospital of New Jersey at Newark Beth Israel Medical Center
Cooperman Barnabas Medical Center
We are entering the season local physicians are most likely to encounter patients with Lyme disease. The majority of early localized and early disseminated Lyme disease occur between April and October with over 50% of cases in June and July. Read more